Bayer has joined the U.S. government in the fight against COVID-19.
After Trump announced what could possibly be the largest public-private partnership ever, companies such as Walmart and Walgreens have united to protect American health.
Now, Bayer has announced that it will donate 3 million tablets of Resochin, otherwise known as Chloroquine.
Multiple reports have surfaced that Chloroquine, which is used to fight Malaria, could potentially work against COVID-19.
Testing is still being done to see how effective and safe the medication is.
See Bayer's announcement below:
The full strength of the private sector has come together to work with the U.S. government to make sure our country remains safe, healthy, and properous.
President Trump was able to convince companies to put aside their competitive nature and to come together for the sake of the American people.
Reuters confirmed the donation of 3 million tablets by Bayer:
Bayer AG said on Thursday it has donated 3 million tablets of the malaria drug Resochin to the U.S. government for potential use to treat COVID-19.
Resochin, made of chloroquine phosphate and an approved treatment for malaria, is being evaluated in China for its potential use against COVID-19, the disease caused by the fast-spreading coronavirus.
U.S. President Donald Trump, speaking at a news conference on Thursday, called on U.S. health regulators to expedite potential therapies such as Gilead Sciences Inc’s Remdesivir and the generic antimalarial drug hydroxychloroquine, aimed at treating COVID-19.
The search for a cure or vaccine is moving faster than any other medical endeavor.
It took 3 years for therapies to be developed during the HIV / AIDS epidemic.
Now, in less than 3 months, a potential treatment is being researched by the FDA and private sector.
The fake news media have been attacking President Trump ever since he touted the potential shown by chloroquine.
Reporters have accused the president of spreading a "false spread of hope" to Americans.
However, The Blaze has details on chloroquine and its potential to change the dynamics of the pandemic:
At a Thursday press briefing, President Donald Trump said that he had directed the Food and Drug Administration to speed up trials of various drugs — including chloroquine — an action which he said could be a potential "game-changer" in fighting the disease.
"Nothing will stand in our way as we pursue any avenue to find what best works against this horrible virus," Trump said at the White House briefing. "Now, a drug called chloroquine — and some people would add to it 'hydroxy,' Hydroxychloroquine — So Chloroquine or Hydroxychloroquine. Now, this is a common malaria drug. It is also a drug used for strong arthritis ... But it is known as a malaria drug, and it's been around for a long time and it's very powerful."
The president also cautioned, "When you go with a brand-new drug, you don't know that that's going to happen" but that the anti-malarial has shown "very, very encouraging early results. And we're going to be able to make that drug available almost immediately."
FDA Commissioner Stephen Hahn explained that while chloroquine has been approved to treat other conditions, the agency wants to get more information about its efficacy against the coronavirus.
For now, "we're looking at drugs that are already approved for other indications; so they're already approved, as the President said, for other diseases," Hahn explained at the briefing.
"As an example, many Americans have read studies and heard media reports about this drug, chloroquine, which is an anti-malarial drug," Hahn explained. "It's already approved — as the President said — for the treatment of malaria, as well as an arthritis condition" but officials wants to get more information in the form of "a large, pragmatic clinical trial."
Countries around the world are using chloroquine experimentally on patients through clinical trials.
There is not yet sufficient clinical evidence to show that this will work, but the early indicators are looking promising.
This story is developing, and we will continue to post updates as medical researchers and scientists discover more about the virus.